These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Combination of direct intratumoral administration of dendritic cells and irradiation induces strong systemic antitumor effect mediated by GRP94/gp96 against squamous cell carcinoma in mice. Akutsu Y; Matsubara H; Urashima T; Komatsu A; Sakata H; Nishimori T; Yoneyama Y; Hoshino I; Murakami K; Usui A; Kano M; Ochiai T Int J Oncol; 2007 Sep; 31(3):509-15. PubMed ID: 17671676 [TBL] [Abstract][Full Text] [Related]
3. Vaccinations with dendritic cells primed with apoptotic tumor cells can elicit preventive antitumor immunity in a poorly immunogenic animal model of squamous cell carcinoma. Jeong HS; Lee H; Ko Y; Son YI Laryngoscope; 2007 Sep; 117(9):1588-93. PubMed ID: 17597627 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic properties of DNA-based fibroblast and dendritic cell vaccines in mice with squamous carcinoma. O-Sullivan I; Kim TS; Chopra A; Cohen EP Anticancer Res; 2006; 26(2A):873-84. PubMed ID: 16619482 [TBL] [Abstract][Full Text] [Related]
5. Strategies for antigen loading of dendritic cells to enhance the antitumor immune response. Strome SE; Voss S; Wilcox R; Wakefield TL; Tamada K; Flies D; Chapoval A; Lu J; Kasperbauer JL; Padley D; Vile R; Gastineau D; Wettstein P; Chen L Cancer Res; 2002 Mar; 62(6):1884-9. PubMed ID: 11912169 [TBL] [Abstract][Full Text] [Related]
6. Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity. Cao X; Zhang W; He L; Xie Z; Ma S; Tao Q; Yu Y; Hamada H; Wang J J Immunol; 1998 Dec; 161(11):6238-44. PubMed ID: 9834111 [TBL] [Abstract][Full Text] [Related]
7. Systemic antitumor effect of intratumoral injection of dendritic cells in combination with local photodynamic therapy. Saji H; Song W; Furumoto K; Kato H; Engleman EG Clin Cancer Res; 2006 Apr; 12(8):2568-74. PubMed ID: 16638867 [TBL] [Abstract][Full Text] [Related]
8. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
9. Administration of interleukin-12 enhances the therapeutic efficacy of dendritic cell-based tumor vaccines in mouse hepatocellular carcinoma. Tatsumi T; Takehara T; Kanto T; Miyagi T; Kuzushita N; Sugimoto Y; Jinushi M; Kasahara A; Sasaki Y; Hori M; Hayashi N Cancer Res; 2001 Oct; 61(20):7563-7. PubMed ID: 11606395 [TBL] [Abstract][Full Text] [Related]
10. Specificity and longevity of antitumor immune responses induced by B7-transfected tumors. Townsend SE; Su FW; Atherton JM; Allison JP Cancer Res; 1994 Dec; 54(24):6477-83. PubMed ID: 7527298 [TBL] [Abstract][Full Text] [Related]
11. Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci. Kanwar JR; Kanwar RK; Pandey S; Ching LM; Krissansen GW Cancer Res; 2001 Mar; 61(5):1948-56. PubMed ID: 11280751 [TBL] [Abstract][Full Text] [Related]
12. Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10. Motomura Y; Senju S; Nakatsura T; Matsuyoshi H; Hirata S; Monji M; Komori H; Fukuma D; Baba H; Nishimura Y Cancer Res; 2006 Feb; 66(4):2414-22. PubMed ID: 16489048 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cells engineered to express the Flt3 ligand stimulate type I immune response, and induce enhanced cytoxic T and natural killer cell cytotoxicities and antitumor immunity. Liu Y; Huang H; Chen Z; Zong L; Xiang J J Gene Med; 2003 Aug; 5(8):668-80. PubMed ID: 12898636 [TBL] [Abstract][Full Text] [Related]
14. Cationic lipid:bacterial DNA complexes elicit adaptive cellular immunity in murine intraperitoneal tumor models. Lanuti M; Rudginsky S; Force SD; Lambright ES; Siders WM; Chang MY; Amin KM; Kaiser LR; Scheule RK; Albelda SM Cancer Res; 2000 Jun; 60(11):2955-63. PubMed ID: 10850443 [TBL] [Abstract][Full Text] [Related]
15. Potentiation of a dendritic cell vaccine for murine renal cell carcinoma by CpG oligonucleotides. Chagnon F; Tanguay S; Ozdal OL; Guan M; Ozen ZZ; Ripeau JS; Chevrette M; Elhilali MM; Thompson-Snipes LA Clin Cancer Res; 2005 Feb; 11(3):1302-11. PubMed ID: 15709202 [TBL] [Abstract][Full Text] [Related]